Melanoma Journal Articles for December 2019

British Journal of Dermatology

Does polygenic risk influence associations between sun exposure and melanoma? A prospective cohort analysis

C.M. Olsen N. Pandeya M.H. Law S. MacGregor M.M. Iles B.S. Thompson A.C. Green R.E. Neale D.C. Whiteman for the QSkin Study

First published: 20 November 2019   https://doi.org/10.1111/bjd.18703


 

Neck Melanoma: Clinical, Dermoscopic and Confocal Features

Borsari S.a · Pampena R.a · Raucci M.a · Mirra M.a · Piana S.b · Pellacani G.c · Longo C.a,c

https://doi.org/10.1159/000503284             Dermatology


NEDD4 Negatively Regulates GITR via Ubiquitination in Immune Microenvironment of Melanoma

Authors Guo Y, Yang L, Lei S, Tan W, Long J

Received 15 April 2019

Accepted for publication 6 November 2019

Published 4 December 2019 Volume 2019:12 Pages 10629—10637

DOI https://doi.org/10.2147/OTT.S212317


Journal of the European Academy of Dermatology and Venereolgy

Late recurrence of melanoma after ten years ? is the course of the disease different from early recurrences?

  1. Sarac, J. Wilhelmi, I. Thomas, U. Leiter, U. Keim, T.K. Eigentler, C. Garbe, T. Amaral

First published: 23 November 2019 https://doi.org/10.1111/jdv.16106


Science Advances

Molecular phenotyping and image-guided surgical treatment of melanoma using spectrally distinct ultrasmall core-shell silica nanoparticles

Feng Chen1,*, Brian Madajewski1,*, Kai Ma2,*, Daniella Karassawa Zanoni3, Hilda Stambuk1, Melik Z. Turker2, Sébastien Monette4, Li Zhang1, Barney Yoo1, Peiming Chen1, Richard J. C. Meester5, Sander de Jonge5, Pablo Montero3, Evan Phillips1,, Thomas P. Quinn6,7, Mithat Gönen8, Sonia Sequeira9, Elisa de Stanchina10, Pat Zanzonico11, Ulrich Wiesner2,, Snehal G. Patel3, and Michelle S. Bradbury1,12,

 

Science Advances  04 Dec 2019:
Vol. 5, no. 12, eaax5208
DOI: 10.1126/sciadv.aax5208


The Lancet Oncology

 

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

Birgit Geoerger, MD Hyoung Jin Kang, MD Michal Yalon-Oren, MD Lynley V Marshall, PhD Catherine Vezina, MD Alberto Pappo, MD et al.

Published:December 04, 2019DOI:https://doi.org/10.1016/S1470-2045(19)30671-0


Human Reproduction

Hormone replacement therapy and the risk of melanoma in post-menopausal women

B M HicksK B KristensenS A PedersenL R HölmichA Pottegård

Human Reproduction, dez222, https://doi.org/10.1093/humrep/dez222

Published: 05 December 2019


British Journal of Dermatology

The interplay of sun?damage and genetic risk in Australian multiple and single primary melanoma cases and controls

E.K. McMeniman, D.L. Duffy, K. Jagirdar, K.J. Lee, E. Peach, A.M. McInerney?Leo, B. De’Ambrosis, J.E. Rayner, B.M. Smithers, H.P. Soyer, R.A. Sturm

First published: 03 December 2019   https://doi.org/10.1111/bjd.18777


The Lancet

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

Birgit Geoerger, MD , Hyoung Jin Kang, MD, Michal Yalon-Oren, MD, Lynley V Marshall, PhD, Catherine Vezina, MD, Alberto Pappo, MD, et al.

Published:December 04, 2019DOI:https://doi.org/10.1016/S1470-2045(19)30671-0


Molecular Cell

Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma 

Marie R. Webster,1,10,12, * Mitchell E. Fane,1 Gretchen M. Alicea,1,3 Subhasree Basu,2 Andrew V. Kossenkov,4 Gloria E. Marino,1 Stephen M. Douglass,1 Amanpreet Kaur,1,3 Brett L. Ecker,1,5 Keerthana Gnanapradeepan,2,6 Abibatou Ndoye,1,3 Curtis Kugel,1 Alexander Valiga,1 Jessica Palmer,1 Qin Liu,2 Xiaowei Xu,7 Jessicamarie Morris,1 Xiangfan Yin,2 Hong Wu,8 Wei Xu,7 Cathy Zheng,7 Giorgos C. Karakousis,7 Ravi K. Amaravadi,7 Tara C. Mitchell,7 Filipe V. Almeida,1 Min Xiao,1 Vito W. Rebecca,1 Ying-Jie Wang,9 Lynn M. Schuchter,7 Meenhard Herlyn,1 Maureen E. Murphy,2 and Ashani T. Weeraratna1,11

https://doi.org/10.1016/j.molcel.2019.11.009


Cancer

Quantitative associations between health insurance and stage of melanoma at diagnosis among nonelderly adults in the United States

Boya Abudu MD, MPH, Kaitlyn A. Cook MA , Jeffrey E. Gershenwald MD, Philip R. Cohen MD, Alan C. Geller MPH, RN

First published: 12 November 2019   https://doi.org/10.1002/cncr.32587


Journal of the National Cancer Institute

Association of Indoor Tanning Exposure With Age at Melanoma Diagnosis and BRAF V600E Mutations

Toni E BurbidgeBoris C BastianDanny GuoHaocheng LiDon G MorrisJose G MonzonGabriella LeungHuiming YangTina Cheng 

Author Notes

JNCI: Journal of the National Cancer Institute, Volume 111, Issue 11, November 2019, Pages 1228–1231, https://doi.org/10.1093/jnci/djz048

Published: 28 March 2019


Journal of the national comprehensive cancer network

Association Between Hospital Volume, Therapy Types, and Overall Survival in Stage III and IV Cutaneous Malignant Melanoma

Authors: Sri Harsha Tella a Anuhya Kommalapati a , b Apar Kishor Ganti c , d and Alissa S. Marr c

Volume/Issue: Volume 17: Issue 11

Online Publication Date: Nov 2019

DOI: https://doi.org/10.6004/jnccn.2019.7320


 

Menu